Acadian Asset Management LLC Reduces Stake in Phibro Animal Health Corporation $PAHC

Acadian Asset Management LLC lowered its holdings in shares of Phibro Animal Health Corporation (NASDAQ:PAHC) by 7.5% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 724,442 shares of the company’s stock after selling 58,497 shares during the period. Acadian Asset Management LLC owned about 1.79% of Phibro Animal Health worth $18,493,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of PAHC. National Bank of Canada FI acquired a new stake in shares of Phibro Animal Health in the first quarter worth approximately $30,000. Financial Management Professionals Inc. acquired a new position in Phibro Animal Health in the 2nd quarter worth $32,000. Quantbot Technologies LP grew its stake in Phibro Animal Health by 53.8% during the 1st quarter. Quantbot Technologies LP now owns 7,870 shares of the company’s stock valued at $168,000 after purchasing an additional 2,754 shares in the last quarter. Yousif Capital Management LLC acquired a new stake in Phibro Animal Health in the second quarter valued at $200,000. Finally, Empirical Financial Services LLC d.b.a. Empirical Wealth Management acquired a new position in Phibro Animal Health in the first quarter worth about $224,000. 99.34% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on the stock. Weiss Ratings raised shares of Phibro Animal Health from a “hold (c+)” rating to a “buy (b-)” rating in a report on Wednesday, November 5th. Bank of America increased their price objective on shares of Phibro Animal Health from $19.00 to $27.00 and gave the stock an “underperform” rating in a research note on Friday, August 29th. Morgan Stanley set a $34.00 target price on Phibro Animal Health in a research note on Thursday, August 28th. Zacks Research upgraded Phibro Animal Health from a “hold” rating to a “strong-buy” rating in a research report on Monday, September 29th. Finally, JPMorgan Chase & Co. increased their target price on Phibro Animal Health from $45.00 to $50.00 and gave the stock an “overweight” rating in a research report on Friday, November 7th. One research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, three have given a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $31.40.

Phibro Animal Health Trading Down 1.1%

Shares of NASDAQ:PAHC opened at $45.33 on Wednesday. The company has a 50 day moving average price of $40.06 and a 200 day moving average price of $31.43. The stock has a market capitalization of $1.84 billion, a price-to-earnings ratio of 38.42, a PEG ratio of 1.24 and a beta of 0.81. The company has a debt-to-equity ratio of 2.46, a quick ratio of 1.25 and a current ratio of 2.76. Phibro Animal Health Corporation has a 1-year low of $16.16 and a 1-year high of $46.42.

Phibro Animal Health (NASDAQ:PAHC) last released its quarterly earnings results on Wednesday, November 5th. The company reported $0.73 earnings per share for the quarter, beating analysts’ consensus estimates of $0.58 by $0.15. The business had revenue of $363.89 million during the quarter, compared to analyst estimates of $345.44 million. Phibro Animal Health had a return on equity of 32.14% and a net margin of 3.73%. Phibro Animal Health has set its FY 2026 guidance at 2.640-2.810 EPS. On average, research analysts anticipate that Phibro Animal Health Corporation will post 1.95 EPS for the current fiscal year.

Phibro Animal Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, December 17th. Shareholders of record on Wednesday, November 26th will be paid a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a yield of 1.1%. The ex-dividend date of this dividend is Wednesday, November 26th. Phibro Animal Health’s payout ratio is 28.92%.

Insider Activity

In other news, CEO Jack Bendheim sold 38,303 shares of the firm’s stock in a transaction on Monday, November 10th. The stock was sold at an average price of $45.29, for a total value of $1,734,742.87. Following the completion of the sale, the chief executive officer owned 20,577 shares of the company’s stock, valued at $931,932.33. This trade represents a 65.05% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Insiders sold a total of 109,159 shares of company stock valued at $4,620,198 in the last ninety days. 50.13% of the stock is owned by corporate insiders.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.